Form 4: Ginkgo Bioworks Executive Steven P. Coen Reports Stock Transactions

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports acquisition and disposal of Class A Common Stock and Restricted Stock Units to cover tax obligations.

Summary

• On November 1, 2024, Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., acquired 587 and 156 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
• Following these transactions, Coen directly owns 6,633 and 6,789 shares of Class A Common Stock respectively.
• On November 4, 2024, Coen disposed of 333 shares of Class A Common Stock at a price of $7.576 per share.
• This disposal was to cover tax withholding obligations related to the vesting of restricted stock and/or restricted stock units, and does not represent discretionary trades.
• After the reported transactions, Coen directly owns 6,456 shares of Class A Common Stock.
• Coen also reports ownership of 17,623 and 6,251 derivative securities (Restricted Stock Units) after the transactions on November 1, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency into the trading activities of company executives and their holdings in the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.

Key Dates